These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36450384)

  • 1. Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries.
    Cortellini A; Dettorre GM; Dafni U; Aguilar-Company J; Castelo-Branco L; Lambertini M; Gennatas S; Angelis V; Sita-Lumsden A; Rogado J; Pedrazzoli P; Viñal D; Prat A; Rossi M; Berardi R; Alonso-Gordoa T; Grisanti S; Dimopoulou G; Queirolo P; Pradervand S; Bertuzzi A; Bower M; Arnold D; Salazar R; Tucci M; Harrington KJ; Mazzoni F; Mukherjee U; Tsourti Z; Michielin O; Pommeret F; Brunet J; Vincenzi B; Tonini G; Patriarca A; Biello F; Krengli M; Tabernero J; Pentheroudakis G; Gennari A; Peters S; Romano E; Pinato DJ
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36450384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases.
    Martin P; Tsourti Z; Ribeiro J; Castelo-Branco L; de Azambuja E; Gennatas S; Rogado J; Sekacheva M; Šušnjar S; Viñal D; Lee R; Khallaf S; Dimopoulou G; Pradervand S; Whisenant J; Choueiri TK; Arnold D; Harrington K; Punie K; Oliveira J; Michielin O; Dafni U; Peters S; Pentheroudakis G; Romano E
    ESMO Open; 2023 Jun; 8(3):101566. PubMed ID: 37285719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study.
    Pinato DJ; Aguilar-Company J; Ferrante D; Hanbury G; Bower M; Salazar R; Mirallas O; Sureda A; Plaja A; Cucurull M; Mesia R; Townsend S; Jackson A; Dalla Pria A; Newsom-Davis T; Handford J; Sita-Lumsden A; Apthorp E; Vincenzi B; Bertuzzi A; Brunet J; Lambertini M; Maluquer C; Pedrazzoli P; Biello F; Sinclair A; Bawany S; Khalique S; Rossi S; Rogers L; Murphy C; Belessiotis K; Carmona-García MC; Sharkey R; García-Illescas D; Rizzo G; Perachino M; Saoudi-Gonzalez N; Doonga K; Fox L; Roldán E; Gaidano G; Ruiz-Camps I; Bruna R; Patriarca A; Martinez-Vila C; Cantini L; Zambelli A; Giusti R; Mazzoni F; Caliman E; Santoro A; Grosso F; Parisi A; Queirolo P; Aujayeb A; Rimassa L; Prat A; Tucci M; Libertini M; Grisanti S; Mukherjee U; Diamantis N; Fusco V; Generali D; Provenzano S; Gennari A; Tabernero J; Cortellini A;
    Lancet Oncol; 2022 Jul; 23(7):865-875. PubMed ID: 35660139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer.
    Pinato DJ; Ferrante D; Aguilar-Company J; Bower M; Salazar R; Mirallas O; Sureda A; Bertuzzi A; Brunet J; Lambertini M; Maluquer C; Pedrazzoli P; Biello F; Lee AJX; Sng CCT; Liñan R; Rossi S; Carmona-García MC; Sharkey R; Eremiev S; Rizzo G; Bain HD; Yu T; Cruz CA; Perachino M; Saoudi-Gonzalez N; Fort-Culillas R; Doonga K; Fox L; Roldán E; Zoratto F; Gaidano G; Ruiz-Camps I; Bruna R; Patriarca A; Shawe-Taylor M; Fusco V; Martinez-Vila C; Berardi R; Filetti M; Mazzoni F; Santoro A; Delfanti S; Parisi A; Queirolo P; Aujayeb A; Rimassa L; Prat A; Tabernero J; Gennari A; Cortellini A;
    Eur J Cancer; 2022 Aug; 171():64-74. PubMed ID: 35704976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry.
    Vincenzi B; Cortellini A; Mazzocca A; Orlando S; Romandini D; Aguilar-Company J; Ruiz-Camps I; Valverde Morales C; Eremiev-Eremiev S; Tondini C; Brunet J; Bertulli R; Provenzano S; Bower M; Generali D; Salazar R; Sureda A; Prat A; Vasiliki M; Van Hemelrijck M; Sita-Lumsden A; Bertuzzi A; Rossi S; Jackson A; Grosso F; Lee AJX; Murphy C; Belessiotis K; Mukherjee U; Pommeret F; Loizidou A; Gaidano G; Dettorre GM; Grisanti S; Tucci M; Fulgenzi CAM; Gennari A; Napolitano A; Pinato DJ
    Ther Adv Med Oncol; 2024; 16():17588359231225028. PubMed ID: 38249336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE).
    Castelo-Branco L; Tsourti Z; Gennatas S; Rogado J; Sekacheva M; Viñal D; Lee R; Croitoru A; Vitorino M; Khallaf S; Šušnjar S; Soewoto W; Cardeña A; Djerouni M; Rossi M; Alonso-Gordoa T; Ngelangel C; Whisenant JG; Choueiri TK; Dimopoulou G; Pradervand S; Arnold D; Harrington K; Michielin O; Dafni U; Pentheroudakis G; Peters S; Romano E
    ESMO Open; 2022 Jun; 7(3):100499. PubMed ID: 35644101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry.
    Mostaghim A; Minkove S; Aguilar-Company J; Ruiz-Camps I; Eremiev-Eremiev S; Dettorre GM; Fox L; Tondini C; Brunet J; Carmona-García M; Lambertini M; Bower M; Newsom-Davis T; Sharkey R; Pria AD; Rossi M; Plaja A; Salazar R; Sureda A; Prat A; Michalarea V; Van Hemelrijck M; Sita-Lumsden A; Bertuzzi A; Rimassa L; Rossi S; Rizzo G; Pedrazzoli P; Lee AJ; Murphy C; Belessiotis K; Diamantis N; Mukherjee U; Pommeret F; Stoclin A; Martinez-Vila C; Bruna R; Gaidano G; D'Avanzo F; Gennari A; Athale J; Eichacker P; Pinato DJ; Torabi-Parizi P; Cortellini A;
    Int J Infect Dis; 2024 Feb; 139():13-20. PubMed ID: 38029831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis.
    Ruiz JI; Lopez-Olivo MA; Geng Y; Suarez-Almazor ME
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36746512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COVID-19 vaccination on the use of PD-1 inhibitor in treating patients with cancer: a real-world study.
    Mei Q; Hu G; Yang Y; Liu B; Yin J; Li M; Huang Q; Tang X; Böhner A; Bryant A; Kurts C; Yuan X; Li J
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35264438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer.
    Tagliamento M; Gennari A; Lambertini M; Salazar R; Harbeck N; Del Mastro L; Aguilar-Company J; Bower M; Sharkey R; Dalla Pria A; Plaja A; Jackson A; Handford J; Sita-Lumsden A; Martinez-Vila C; Matas M; Miguel Rodriguez A; Vincenzi B; Tonini G; Bertuzzi A; Brunet J; Pedrazzoli P; D'Avanzo F; Biello F; Sinclair A; Lee AJX; Rossi S; Rizzo G; Mirallas O; Pimentel I; Iglesias M; Sanchez de Torre A; Guida A; Berardi R; Zambelli A; Tondini C; Filetti M; Mazzoni F; Mukherjee U; Diamantis N; Parisi A; Aujayeb A; Prat A; Libertini M; Grisanti S; Rossi M; Zoratto F; Generali D; Saura C; Lyman GH; Kuderer NM; Pinato DJ; Cortellini A
    J Clin Oncol; 2023 May; 41(15):2800-2814. PubMed ID: 36720089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World Clinical and Economic Outcomes in Selected Immune-Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors.
    Zheng Y; Kim R; Yu T; Gayle JA; Wassel CL; Dreyfus J; Phatak H; George S
    Oncologist; 2021 Nov; 26(11):e2002-e2012. PubMed ID: 34327774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
    Pinato DJ; Tabernero J; Bower M; Scotti L; Patel M; Colomba E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Dalla Pria A; Aguilar-Company J; Ottaviani D; Chowdhury A; Merry E; Salazar R; Bertuzzi A; Brunet J; Lambertini M; Tagliamento M; Pous A; Sita-Lumsden A; Srikandarajah K; Colomba J; Pommeret F; Seguí E; Generali D; Grisanti S; Pedrazzoli P; Rizzo G; Libertini M; Moss C; Evans JS; Russell B; Harbeck N; Vincenzi B; Biello F; Bertulli R; Liñan R; Rossi S; Carmona-García MC; Tondini C; Fox L; Baggi A; Fotia V; Parisi A; Porzio G; Saponara M; Cruz CA; García-Illescas D; Felip E; Roqué Lloveras A; Sharkey R; Roldán E; Reyes R; Earnshaw I; Ferrante D; Marco-Hernández J; Ruiz-Camps I; Gaidano G; Patriarca A; Bruna R; Sureda A; Martinez-Vila C; Sanchez de Torre A; Cantini L; Filetti M; Rimassa L; Chiudinelli L; Franchi M; Krengli M; Santoro A; Prat A; Van Hemelrijck M; Diamantis N; Newsom-Davis T; Gennari A; Cortellini A;
    Lancet Oncol; 2021 Dec; 22(12):1669-1680. PubMed ID: 34741822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry.
    Cortellini A; Tabernero J; Mukherjee U; Salazar R; Sureda A; Maluquer C; Ferrante D; Bower M; Sharkey R; Mirallas O; Plaja A; Cucurull M; Mesia R; Dalla Pria A; Newsom-Davis T; Van Hemelrijck M; Sita-Lumsden A; Apthorp E; Vincenzi B; Di Fazio GR; Tonini G; Pantano F; Bertuzzi A; Rossi S; Brunet J; Lambertini M; Pedrazzoli P; Biello F; D'Avanzo F; Lee AJX; Shawe-Taylor M; Rogers L; Murphy C; Cooper L; Andaleeb R; Khalique S; Bawany S; Ahmed S; Carmona-García MC; Fort-Culillas R; Liñan R; Zoratto F; Rizzo G; Perachino M; Doonga K; Gaidano G; Bruna R; Patriarca A; Martinez-Vila C; Pérez Criado I; Giusti R; Mazzoni F; Antonuzzo L; Santoro A; Parisi A; Queirolo P; Aujayeb A; Rimassa L; Diamantis N; Bertulli R; Fulgenzi CAM; D'Alessio A; Ruiz-Camps I; Saoudi-Gonzalez N; Garcia Illescas D; Medina I; Fox L; Gennari A; Aguilar-Company J; Pinato DJ;
    Lancet Oncol; 2023 Apr; 24(4):335-346. PubMed ID: 36898391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry.
    ; Pinato DJ; Patel M; Scotti L; Colomba E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Dalla Pria A; Aguilar-Company J; Bower M; Salazar R; Bertuzzi A; Brunet J; Lambertini M; Tagliamento M; Pous A; Sita-Lumsden A; Srikandarajah K; Colomba J; Pommeret F; Seguí E; Generali D; Grisanti S; Pedrazzoli P; Rizzo G; Libertini M; Moss C; Evans JS; Russell B; Harbeck N; Vincenzi B; Biello F; Bertulli R; Ottaviani D; Liñan R; Rossi S; Carmona-García MC; Tondini C; Fox L; Baggi A; Fotia V; Parisi A; Porzio G; Queirolo P; Cruz CA; Saoudi-Gonzalez N; Felip E; Roqué Lloveras A; Newsom-Davis T; Sharkey R; Roldán E; Reyes R; Zoratto F; Earnshaw I; Ferrante D; Marco-Hernández J; Ruiz-Camps I; Gaidano G; Patriarca A; Bruna R; Sureda A; Martinez-Vila C; Sanchez de Torre A; Berardi R; Giusti R; Mazzoni F; Guida A; Rimassa L; Chiudinelli L; Franchi M; Krengli M; Santoro A; Prat A; Tabernero J; Van Hemelrijck M; Diamantis N; Gennari A; Cortellini A
    JAMA Oncol; 2022 Jan; 8(1):114-122. PubMed ID: 34817562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses to SARS-CoV-2 in vaccinated patients receiving checkpoint blockade immunotherapy for cancer.
    Piening A; Ebert E; Khojandi N; Alspach E; Teague RM
    Front Immunol; 2022; 13():1022732. PubMed ID: 36582225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-Related Adverse Events Among COVID-19-Vaccinated Patients With Cancer Receiving Immune Checkpoint Blockade.
    Widman AJ; Cohen B; Park V; McClure T; Wolchok J; Kamboj M
    J Natl Compr Canc Netw; 2022 Oct; 20(10):1134-1138. PubMed ID: 36240845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer.
    Cortellini A; Aguilar-Company J; Salazar R; Bower M; Sita-Lumsden A; Plaja A; Lee AJX; Bertuzzi A; Tondini C; Diamantis N; Martinez-Vila C; Prat A; Apthorp E; Gennari A; Pinato DJ
    Br J Cancer; 2022 Nov; 127(10):1787-1792. PubMed ID: 35995934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey.
    Ghosh N; Tirpack A; Chan KK; Bass AR
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33067320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors.
    Nuzzo PV; Pond GR; Abou Alaiwi S; Nassar AH; Flippot R; Curran C; Kilbridge KL; Wei XX; McGregor BA; Choueiri T; Harshman LC; Sonpavde G
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32234849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer.
    Allouchery M; Lombard T; Martin M; Rouby F; Sassier M; Bertin C; Atzenhoffer M; Miremont-Salame G; Perault-Pochat MC; Puyade M;
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33428586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.